Olema Pharmaceuticals, Inc. — Investor Relations & Filings
Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women's cancers. The company concentrates on endocrine-driven diseases, with a primary emphasis on breast cancer. Its lead product candidate, palazestrant (OP-1250), is an oral complete estrogen receptor (ER) antagonist (CERAN) and selective ER degrader (SERD). Palazestrant is under investigation in clinical trials as a potential treatment for patients with ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is advancing a pipeline of drug candidates with the goal of developing improved therapeutic options for cancer patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-26 | English | |
| 8-K | 2026-05-21 | English | |
| 10-Q - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-12 | English | |
| 8-K - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-12 | English | |
| 8-K - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-01 | English | |
| SCHEDULE 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject) | 2026-03-20 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47060269 | 8-K | 2026-05-26 | English | ||
| 46753709 | 8-K | 2026-05-21 | English | ||
| 45235873 | 10-Q - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-12 | English | ||
| 45234135 | 8-K - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-12 | English | ||
| 39647982 | 8-K - Olema Pharmaceuticals, Inc. (0001750284) (Filer) | 2026-05-01 | English | ||
| 32999839 | SCHEDULE 13G - Olema Pharmaceuticals, Inc. (0001750284) (Subject) | 2026-03-20 | English | ||
| 31582743 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31582732 | 4 Filing | 2026-02-17 | English | ||
| 31582675 | 3 Filing | 2026-02-17 | English | ||
| 31582686 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 31582850 | SCHEDULE 13G Filing | 2026-02-05 | English | ||
| 31582849 | 4 Filing | 2026-02-04 | English | ||
| 31582785 | 4 Filing | 2026-02-04 | English | ||
| 31582739 | 4 Filing | 2026-02-04 | English | ||
| 31582729 | 4 Filing | 2026-02-04 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Olema Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32591/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32591 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32591 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32591 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32591}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Olema Pharmaceuticals, Inc. (id: 32591)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.